<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ADXN
Addex Therapeutics
$
()


  • Fly Intel: Pre-Market Movers

    4/3/2024 - 08:41am
  • Addex Therapeutics, Perceptive Advisors launch Neurosterix

    4/3/2024 - 08:20am
  • Addex Therapeutics Ltd - ADR trading resumes

    12/5/2023 - 16:00pm
  • Addex Therapeutics Ltd - ADR trading halted, volatility trading pause

    12/5/2023 - 15:54pm
  • Addex Therapeutics completes recruitment of patients in ADX71149

    11/14/2023 - 05:48am
  • Addex Therapeutics regains compliance with Nasdaq

    11/8/2023 - 05:24am
  • Addex Therapeutics announces one for twenty reverse ADS split

    10/6/2023 - 16:04pm
  • Addex Therapeutics announces ADX71149 study readout expected in 2Q24

    9/5/2023 - 05:22am
  • Addex Therapeutics announces CHF 2.7M commitment from Indivior

    8/3/2023 - 05:43am
  • Addex Therapeutics publishes potential treatment for opioid use disorder data

    7/24/2023 - 05:23am
  • Addex Therapeutics increases share capital to create treasury shares

    6/15/2023 - 05:18am
  • Addex Therapeutics receives noncompliance notification from Nasdaq

    5/18/2023 - 05:13am
  • Addex Therapeutics announces IRC recommendation to continue ADX71149 trial

    5/10/2023 - 05:35am
  • Addex Therapeutics files to sell 13.23M ADS for holders

    5/3/2023 - 16:08pm
dynamic_feed Breaking News